PureTech Health (PRTC) Competitors $18.39 +0.03 (+0.16%) As of 02:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. APGE, IMCR, DYN, CDTX, TWST, TVTX, BHVN, AUPH, SDGR, and EVOShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Apogee Therapeutics (APGE), Immunocore (IMCR), Dyne Therapeutics (DYN), Cidara Therapeutics (CDTX), Twist Bioscience (TWST), Travere Therapeutics (TVTX), Biohaven (BHVN), Aurinia Pharmaceuticals (AUPH), Schrodinger (SDGR), and Evotec (EVO). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Its Competitors Apogee Therapeutics Immunocore Dyne Therapeutics Cidara Therapeutics Twist Bioscience Travere Therapeutics Biohaven Aurinia Pharmaceuticals Schrodinger Evotec Apogee Therapeutics (NASDAQ:APGE) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Do analysts recommend APGE or PRTC? Apogee Therapeutics currently has a consensus price target of $99.00, indicating a potential upside of 171.38%. PureTech Health has a consensus price target of $45.00, indicating a potential upside of 144.68%. Given Apogee Therapeutics' higher probable upside, equities analysts clearly believe Apogee Therapeutics is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apogee Therapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do insiders & institutionals believe in APGE or PRTC? 79.0% of Apogee Therapeutics shares are owned by institutional investors. Comparatively, 0.0% of PureTech Health shares are owned by institutional investors. 42.8% of Apogee Therapeutics shares are owned by company insiders. Comparatively, 5.3% of PureTech Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer APGE or PRTC? In the previous week, Apogee Therapeutics had 3 more articles in the media than PureTech Health. MarketBeat recorded 5 mentions for Apogee Therapeutics and 2 mentions for PureTech Health. PureTech Health's average media sentiment score of 0.72 beat Apogee Therapeutics' score of -0.16 indicating that PureTech Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apogee Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral PureTech Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is APGE or PRTC more profitable? PureTech Health's return on equity of 0.00% beat Apogee Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Apogee TherapeuticsN/A -34.65% -32.76% PureTech Health N/A N/A N/A Which has more volatility & risk, APGE or PRTC? Apogee Therapeutics has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Which has better earnings & valuation, APGE or PRTC? PureTech Health has higher revenue and earnings than Apogee Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApogee TherapeuticsN/AN/A-$182.15M-$4.13-8.83PureTech Health$4.32M102.85$27.78MN/AN/A SummaryPureTech Health beats Apogee Therapeutics on 7 of the 13 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$443.81M$3.12B$5.76B$9.55BDividend YieldN/A2.23%4.53%4.07%P/E RatioN/A20.4630.4325.11Price / Sales102.85237.31392.2187.48Price / Cash7.7842.3737.0358.50Price / Book1.087.959.016.20Net Income$27.78M-$54.72M$3.26B$265.38M7 Day Performance5.09%1.56%1.00%-1.25%1 Month Performance-0.92%5.71%4.19%-0.81%1 Year Performance-14.67%9.01%28.39%18.83% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health2.7804 of 5 stars$18.39+0.2%$45.00+144.7%-15.7%$443.81M$4.32M0.00100News CoverageUpcoming EarningsShort Interest ↓APGEApogee Therapeutics3.44 of 5 stars$34.65-2.1%$99.00+185.7%-26.5%$1.63BN/A-9.6391IMCRImmunocore1.9622 of 5 stars$31.89-0.3%$58.00+81.9%-12.4%$1.61B$310.20M-79.73320DYNDyne Therapeutics3.0883 of 5 stars$11.24+0.7%$34.94+210.8%-74.4%$1.59BN/A-2.91100CDTXCidara Therapeutics3.5095 of 5 stars$62.00flat$64.14+3.5%+402.2%$1.57B$1.27M-5.5790TWSTTwist Bioscience4.1334 of 5 stars$27.63+7.8%$49.40+78.8%-38.4%$1.55B$312.97M-19.06990TVTXTravere Therapeutics2.5878 of 5 stars$17.28+2.0%$32.21+86.4%+101.9%$1.51B$233.18M-8.47460BHVNBiohaven3.7856 of 5 stars$13.42-8.9%$58.46+335.5%-64.2%$1.51BN/A-1.43239Analyst ForecastAUPHAurinia Pharmaceuticals2.9781 of 5 stars$11.43+0.5%$12.00+5.0%+86.8%$1.50B$235.13M26.58300Positive NewsSDGRSchrodinger2.8975 of 5 stars$18.63-3.0%$32.75+75.8%-5.5%$1.41B$207.54M-7.51790Analyst ForecastEVOEvotec1.7537 of 5 stars$3.81-3.1%$5.90+54.9%+11.6%$1.40B$862.40M0.004,827Analyst Revision Related Companies and Tools Related Companies APGE Alternatives IMCR Alternatives DYN Alternatives CDTX Alternatives TWST Alternatives TVTX Alternatives BHVN Alternatives AUPH Alternatives SDGR Alternatives EVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access